Figure 2.
Comparison of progression-free survival between patients with and without a T790M epidermal growth factor receptor (EGFR) mutation prior to treatment with an EGFR tyrosine-kinase inhibitor.
Note: Weights are from random-effects analysis.
Abbreviations: CI, confidence interval; HR, hazard ratio.